Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Cannabinoid pharmacology: the first 66 years.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Recent Gains in Clinical Multiple Sclerosis Research Review.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
[Posture disorders in patients with multiple sclerosis.]
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
The benefits of exercise training in multiple sclerosis.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.

Pages